Skip to content

The effect of capsaicin and cinnamaldehyde on intestinal permeability, gallbladder motility and satiety

The effect of capsaicin and cinnamaldehyde on intestinal permeability, gallbladder motility and satiety - Capsaicine protocol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34052
Enrollment
15
Registered
2010-10-27
Start date
2011-03-03
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gallbladder motility leaky gut

Interventions

Duodenal infusion of capsaicin / cinnamaldehyde / saline (placebo)

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) Based on medical history and previous examination, no gastrointestinal complaints can be defined. 2) Age between 18 and 65 years 3) BMI between 20 and 30 kg/m2

Exclusion criteria

Exclusion criteria: 1) History of severe cardiovascular, respiratory, urogenital, gastrointestinal/ hepatic, hematological/immunologic, HEENT (head, ears, eyes, nose, throat), dermatological/¬connective tissue, musculoskeletal, metabolic/nutritional, endocrine, neurological/¬psychiatric diseases, allergy, major surgery and/or laboratory assessments which might limit participation in or completion of the study protocol. The severity of the disease (major interference with the execution of the experiment or potential influence on the study outcomes) will be decided by the principal investigator. 2) Use of medication, including vitamin supplementation, except oral contraceptives, within 14 days prior to testing 3) Administration of investigational drugs or participation in any scientific intervention study which may interfere with this study (to be decided by the principle investigator), in the 180 days prior to the study 4) Major abdominal surgery interfering with gastrointestinal function (uncomplicated appendectomy, cholecystectomy and hysterectomy allowed, and other surgery upon judgement of the principle investigator) 5) Dieting (medically prescribed, vegetarian, diabetic, macrobiological, biological dynamic), pregnancy, lactation 6) Excessive alcohol consumption (>20 alcoholic consumptions per week) 7) Smoking 8) Blood donation within 3 months before the study period 9) Self-admitted HIV-positive state

Design outcomes

Primary

MeasureTime frame
The primary aim is to assess intestinal permeability by means of sugar permeability test

Secondary

MeasureTime frame
Secondary outcomes of the study are to assess tight junction functionality in duodenal biopsy specimens and to assess gallbladder motility and effects on satiety.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)